Publications & Works

Publication Network
Journal articles indexed in SCI, SSCI, and AHCI 24

Evaluation of thiol/disulfide homeostasis and ischemia-modified albumin levels in patients diagnosed with heroin use disorder

Sahiner S. Y., Baysal D., Vayisoglu T., Avcioglu G., YILMAZ F. M., EREL Ö.
Heroin Addiction and Related Clinical Problems , vol.2025, no.27, 2025 (SSCI) identifier

Affective neuroscience personality traits in opioid use disorder patients: The relationship with earlier onset of substance use, the severity of addiction, and motivational factors to quit opiate use

Aşut G., Alıcı Y. H., Ceran S., Danışman M., Şahiner Ş. Y.
Brain and Behavior , vol.14, no.9, 2024 (SCI-Expanded) identifier identifier

Menstrual Psychosis with Premenstrual Onset: A case presentation

Turkan S., KARA E., İLHAN R. S., YALÇIN ŞAHİNER Ş., SAKA M. C.
EUROPEAN PSYCHIATRY , 2024 (SCI-Expanded) identifier

Comparison of the immunoassay method with the commercial and in-house LC-MS/MS methods for substance abuse in urine

Avcioglu G., YILMAZ G., Sahiner Ş., KOZACI L. D., BAL C., YILMAZ F. M.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , no.1, pp.24-37, 2024 (SCI-Expanded) Creative Commons License Sustainable Development identifier

Evaluating substance-related dreams and their impact on the treatment process through the mechanism of censorship in dreams. A pilot study

Danisman M., Colace C., Sahiner S. Y., Polat H.
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS , 2024 (SSCI) identifier

Comparison of Attachment Styles of Individuals with Opioid Use Disorder and Individuals with Obesity

Acidere A. B., Asan O., YALÇIN ŞAHİNER Ş., ŞAHİNER İ. V., Goka E.
TURK PSIKIYATRI DERGISI , 2023 (SSCI) Sustainable Development identifier identifier

Association of OPRK1 rs963549 and rs997917 polymorphisms with opioid use disorder and the related phenotypes

Ozkan-Kotiloglu S., AKYÜZLÜ D., Yalcin-Sahiner Ş., Ayaz N.
PHARMACOGENOMICS , vol.24, no.6, pp.325-334, 2023 (SCI-Expanded) identifier identifier identifier

Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder

Kaya-Akyuzlu D., Ozkan-Kotiloglu S., Bal C., Avcioglu G., Yalcin-Sahiner Ş., Sahiner I. V.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , vol.95, 2022 (SCI-Expanded) identifier identifier identifier

Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use

AKYÜZLÜ D., Özkan-Kotiloğlu S., Yalçın-Şahiner Ş., Ağtaş-Ertan E., Özgür-İlhan İ.
EUROPEAN JOURNAL OF PHARMACOLOGY , vol.921, 2022 (SCI-Expanded) identifier identifier identifier

Effects of family functions on Opioid Use Disorder patients to remission

Sahiner I. V., Ucan Y., Sahiner Ş.
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS , vol.24, no.1, pp.39-45, 2022 (SSCI) Sustainable Development identifier identifier

Association of Glial Cell-Line Derived Neurotrophic Factor and Nerve Growth Factor with Duration of Untreated Psychosis and Clinical Symptoms in Drug-Naive Schizophrenia

Tikir B., Asan O., Uzdogan A., Sahiner Ş., Goka E.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.31, no.3, pp.252-260, 2021 (SCI-Expanded) identifier identifier identifier

Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls

Avcioglu G., YILMAZ G., Sahiner Ş., KOZACI L. D., BAL C., YILMAZ F. M.
CLINICAL BIOCHEMISTRY , vol.93, pp.112-118, 2021 (SCI-Expanded) identifier identifier identifier

Effect of PDYN rs2281285, rs2235749 and rs910080 gene polymorphisms on the intensity of depression symptoms and negative craving in heroin addicts

AKYÜZLÜ D., Ozkan-Kotiloglu S., YALÇIN ŞAHİNER Ş., Ayaz N.
ARCHIVES OF BIOLOGICAL SCIENCES , vol.73, no.4, pp.473-482, 2021 (SCI-Expanded) identifier identifier

DTI-MRI findings in synthetic cannabinoid users

Gokharman D., Aydin S., Paltun S., FATİHOĞLU E., YALÇIN ŞAHİNER Ş., Kosar P. N.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.4, pp.1022-1027, 2020 (SCI-Expanded) identifier identifier identifier identifier

Pregabalin abuse among patients with opioid use disorders may increase the severity of withdrawal symptoms: a single-center, case-control study

Ekici O. C., Sahiner V., Erzin G., Ocak D., Sahiner Ş., Goka E.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.29, no.4, pp.479-483, 2019 (SCI-Expanded) identifier identifier

How probation affects treatment of Opioid Use Disorders: Comparison of early remission rates between Opioid Use Disorder patients admitted to medical clinic voluntarily and by probation

Asan O., Sahiner I. V., Sahiner Ş., Goka E.
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS , vol.21, no.5, pp.53-60, 2019 (SSCI) identifier identifier

Comparison of sociodemographic features, psychopathy and aggression levels of criminal and non-criminal schizophrenia patients

GÜRKAN Ş., TATLIDİL YAYLACI E., ÖZDEMİR Ç., ÇATLI B., YALÇIN ŞAHİNER Ş., GÜRKAN D., et al.
ANADOLU PSIKIYATRI DERGISI , vol.20, no.3, pp.261-268, 2019 (SCI-Expanded) identifier identifier identifier

Majör depresif bozukluk tanısı ile başvuran hastalarda beden kitle indeksinin depresyon şiddeti, yeme tutumu ve dürtüsellikle ilişkisi

ÖZTÜRK M., ŞAHİNER İ. V., YALÇIN ŞAHİNER Ş., ÇAYKÖYLÜ A.
ANADOLU PSIKIYATRI DERGISI , vol.19, no.2, pp.117-125, 2018 (SCI-Expanded) identifier identifier

Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia

Bakirhan A., Sahiner Ş., Sahiner I. V., Safak Y., Goka E.
PLOS ONE , vol.12, no.12, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

Thiol/disulfide homeostasis in untreated schizophrenia patients

Topcuoglu C., Bakirhan A., YILMAZ F. M., NEŞELİOĞLU S., EREL Ö., Sahiner Ş.
PSYCHIATRY RESEARCH , vol.251, pp.212-216, 2017 (SCI-Expanded) identifier identifier identifier

TNF-related weak inducer of apoptosis (TWEAK) levels in schizophrenia

Yaylaci E. T., Yuksel R. N., ÜNAL K., Altunsoy N., Cingi M., Sahiner Ş., et al.
PSYCHIATRY RESEARCH , vol.229, no.3, pp.755-759, 2015 (SCI-Expanded) identifier identifier identifier

Premorbid Personality Disorders in Male Schizophrenic Patients with or without Comorbid Substance Use Disorder: Is Dual Diagnosis Mediated by Personality Disorder?

Altunsoy N., Sahiner Ş., Kuluk M. C., Okay T., Kaymak S. U., Aydemir C., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.52, no.3, pp.303-308, 2015 (SCI-Expanded) identifier identifier identifier

Effects of the Adverse Life Events and Disrupted in Schizophrenia-1 (DISC1) Gene Polymorphisms on Acute Symptoms of Schizophrenia

Sayin A., Yuksel N., KONAÇ E., Yilmaz A., Dogan B., Tonge S., et al.
DNA AND CELL BIOLOGY , vol.32, no.2, pp.73-80, 2013 (SCI-Expanded) identifier identifier identifier

A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study

Dogruman-Al F., ASLAN S., Yalcin Ş., Kustimur S., Turk S.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE , vol.13, no.1, pp.82-87, 2009 (SCI-Expanded) identifier identifier identifier
Articles Published in Other Journals 6

Opioid Kullanım Bozukluğu Olan Hastalarda Psikolojik Dayanıklılığın Tedavi Devamlılığı İle İlişkisi

YALÇIN ŞAHİNER Ş., AŞUT G., ŞAHİNER İ. V.
BAGIMLIK DERGISI , vol.23, no.3, pp.256-265, 2022 (Peer-Reviewed Journal) identifier

Evaluation of balance with video head impulse test and vestibulospinal tests in patients with substance use disorder

AYDIN A., KUTLUHAN A., YALÇIN ŞAHİNER Ş., ÇEKİÇ Ş.
Annals of Medical Research , vol.29, no.1, pp.73-76, 2022 (Peer-Reviewed Journal) identifier

EFFECTS OF LIFE EVENTS AND TEMPERAMENT, PERSONALITY TRAITS IN PATIENTS WITH ACUTE ISCHEMIC STROKE AND TRANSIENT ISCHEMIC ATTACK

ŞAHİNER İ. V., AYTAÇ E., ARTIK H. A. Ü., ŞAHİNER Ş. Y., AKYÜZ A., ÖZTÜRK M., et al.
Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.54, no.2, pp.263-270, 2021 (Peer-Reviewed Journal) Creative Commons License identifier

Relationship between somatization and psychiatric symptoms, especially anxiety, depression, alexithymia, and severity of addiction in male patients with alcohol and heroin addiction

AKSU M. H., YALÇIN ŞAHİNER Ş., ŞAHİNER İ. V., KOPARAL B., UTKU Ç., COŞAR B., et al.
DUSUNEN ADAM , vol.33, no.2, pp.120-129, 2020 (ESCI) identifier identifier

Naltrekson Cilt Altı İmplant Uygulaması Sonrası Gelişen Cilt Reaksiyonu

PALTUN S. C., YALÇIN ŞAHİNER Ş., KAYA H., GÖKA E.
Current Addiction Research , vol.1, no.2, pp.72-74, 2017 (Peer-Reviewed Journal)

The Impact Role of Childhood Traumas and Life Events in Patients with Alopecia Aerate and Psoriasis

ŞAHİNER İ. V., TAŞKINTUNA N., ŞEVİK A. E., KARADAĞ KÖSE Ö., ATAŞ H., YALÇIN ŞAHİNER Ş., et al.
Journal of Psychiatry , vol.17, no.6, pp.115-120, 2014 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 25

The relationship between addiction and endocrine system

Baysal D., Yalçın Şahiner Ş.
The 5th Regional International Association of Forensic Toxicologists (TIAFT) Meeting in Türkiye, Diyarbakır, Turkey, 9 - 11 October 2024, (Unpublished)

Trends and Challenges of New Psychoactive Substances in Türkiye: A Decade of Change

Avcı Akca A., Dağlıoğlu N., Ertaş B. S., Yalçın Şahiner Ş., Ünüvar N.
5th Regional Tiaft Meeting in Türkiye, Diyarbakır, Turkey, 9 - 11 October 2024, (Summary Text)

What Do Neuroimaging Techniques Reveal in the Context of Addiction Research? How Can These Findings Be Translated into Clinical Application?

Yalçın Şahiner Ş.
ISAM 2024 CONGRESS, İstanbul, Turkey, 5 - 08 September 2024, (Unpublished)

Segmental analysis of multi-illicit drugs in head hair of patients treated in a rehabilitation program

Danışman M., GÖREN İ. E., ATASOY AYDIN A., YALÇIN ŞAHİNER Ş., Ertaş B. S., Soytürk H., et al.
61st Annual Meeting of TIAFT, St. Gallen, Switzerland, 2 - 06 September 2024, (Summary Text)

Food Addiction and Substance Abuse

YALÇIN ŞAHİNER Ş.
12th International Congress on Psycoharmacology and 8th İnternational Symposium on Child and Adolescent Psychopharmacology, 17 - 20 November 2021, (Summary Text)

Comparison Of Childhood Trauma And Personality Features Of Alcohol And Substance Addicts

YALÇIN ŞAHİNER Ş., ŞAHİNER İ. V., BAKIRHAN A., ARIKAN Z.
ISARC, INTERNATIONAL ADDICTION CONGRESS, 24 - 25 July 2021, (Full Text)

Association Between Pdyn rs2281285, rs2235749, rs910080 Gene Polymorphisms And Heroın Dependence Susceptibilty

AKYÜZLÜ D., ÖZKAN KOTİLOĞLU S., YALÇIN ŞAHİNER Ş., Ayaz N.
1. INTERNATIONAL ADDICTION CONGRESS, Ankara, Turkey, 24 July 2021, (Full Text)

Effect Of OPRM1 A118G Polymorphism On Plasma Beta-Endorphin And Dose-Adjusted Buprenorpine Levels In Heroin Addicts

AKYÜZLÜ D., ÖZKAN KOTİLOĞLU S., BAL C., Avcıoğlu G., YALÇIN ŞAHİNER Ş., ŞAHİNER İ. V.
1. INTERNATIONAL ADDICTION CONGRESS, Ankara, Turkey, 24 July 2021, (Full Text)

Opioid Kullanım Bozuklukları ve Endokrin Sistem

YALÇIN ŞAHİNER Ş.
12. Ulusal Alkol ve Madde Bağımlılığı Kongresi, 29 November - 02 December 2018, (Summary Text)

Depo Antagonist Kullanımı

YALÇIN ŞAHİNER Ş.
11. Alkol ve Madde Bağımlılığı Kongresi, 23 - 26 November 2017, (Summary Text)

Impulsivity and Sociodemographic Characteristics in Patients with Alcohol Use Disorder

ÖZTÜRK M., ÖZDEMİR I., KURU E., ŞAHİNER İ. V., YALÇIN ŞAHİNER Ş.
9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, 26 - 30 April 2017, (Summary Text)

Persistent genital arousal disorder due to duloxetine withdrawal

TÜRKKAN E., YALÇIN ŞAHİNER Ş., TATLIDİL YAYLACI E., YİRUN O., GÖKA E.
9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, 26 - 30 April 2017, (Summary Text)

Association of Serum Brain Derived Neurotrophic Factor with Duration of Drug-Naive Period and Positive-Negative Symptom Scores in Drug-Naive Schizophrenia

BAKIRHAN A., YALÇIN ŞAHİNER Ş., ŞAFAK Y.
9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, 26 - 30 April 2017, (Summary Text)

The Effect of Demographic Characteristics on Symptom Scores in Untreated Schizophrenic Patients

BAKIRHAN A., YALÇIN ŞAHİNER Ş., ŞAHİNER İ. V.
9th International Congress on Psychopharmacology, 5th International Symposium on Child and Adolescent Psychopharmacology, 26 - 30 April 2017, (Summary Text)

Psychotic mania after the use of slimming pill that contain Acai Berry: case report

TIKIR B., YALÇIN ŞAHİNER Ş., GÖKA E.
9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology, 26 - 30 April 2017, (Summary Text)

Opiyat Kullanım Bozuklukları

YALÇIN ŞAHİNER Ş.
6. Ulusal Ergen Sağlığı Kongresi, 31 March - 01 April 2017, (Summary Text)

Bağımlılıkta nüksü önlemeye yönelik güncel yaklaşımlar

YALÇIN ŞAHİNER Ş.
10. Ulusal Alkol ve Madde Bağımlılığı Kongresi, 14 - 17 December 2016, (Summary Text)

On Soruda Bir Konu 1: Bariatrik cerrahi hastalarında bağımlılık

YALÇIN ŞAHİNER Ş.
52. Ulusal Psikiyatri Kongresi, 16 - 20 November 2016, (Summary Text)

Bağımlılıkta Hekim İletişimi

YALÇIN ŞAHİNER Ş.
2. Sağlık İletişimi Sempozyumu, 3 - 04 November 2016, (Summary Text)

Ülkemizde Bağımlılık ve Klinisyenlerin Laboratuvardan Beklentisi

YALÇIN ŞAHİNER Ş.
Uluslararası Katılımlı Kongre Lab. Expo 2016, 27 September - 01 October 2016, (Summary Text)

Yoğun Bakımda Bir NMS Olgusu: EKT Hayat Kurtarıcı Olabilir Mi?

YİRUN O., YALÇIN ŞAHİNER Ş., CİNGİ M., TATLIDİL YAYLACI E.
Türkiye Psikiyatri Demeği 19. Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, 6 - 09 May 2015, (Summary Text)

Serebral palsili bipolar duygudurum bozukluğu hastasında EKT uygulaması

ÇITAK EKİCİ Ö., YALÇIN ŞAHİNER Ş., TATLIDİL YAYLACI E., GÖKA E., ÇAKIR M.
50. Ulusal Psikiyatri Kongresi, 12 - 14 November 2014, (Summary Text)

Psikiyatrik Belirtilerle Başvuran Bir Lyme Olgusu

GÜRKAN Ş., TATLIDİL YAYLACI E., YILDIRIR B., YALÇIN ŞAHİNER Ş., GÖKA E.
50. Ulusal Psikiyatri Kongresi, 12 - 14 November 2014, (Summary Text)

A suicide attempt, not taking but saving a life

TÜRKKAN E., YAYLACI TATLIDİL E., YALÇIN ŞAHİNER Ş., CİNGİ M., GÖKA E.
6th International Congress on Psychopharmacology & 2nd International Symposium on Child and Adolescent Psychopharmacology, 16 - 20 April 2014, (Summary Text)

Coping strategies for patients with alcohol dependence who are in remission or not: a controlled study

TANER E., ŞAHİNER Ş., ARIKAN Z.
21th European Congress of Psychiatry, 6 - 09 April 2013, (Summary Text) identifier
Books 5

Forensic Psychiatric Expert in the Context of Turkish Criminal Law for Substance Use Disorder

Yalçın Şahiner Ş., Baysal D.
in: Forensic Psychiatric Expertise in the Turkish Legal System, Aliustaoğlu FS, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.9-13, 2024

7. Bölüm: Uyuşturucu ve Uyarıcı Madde Bağımlılığında Tanı ve Tedavi

Yalçın Şahiner Ş., Şahiner İ. V.
in: Her YönüyleBAĞIMLILIK, ŞAHİN CENGİZ, özkan ayhan, BULUT YUNUS EMRE, Editor, Pegem Akademi, Ankara, pp.115-129, 2024

Madde Kullanım Bozukluğuna Genel Yaklaşım

YALÇIN ŞAHİNER Ş.
in: Acil Servislerde Madde Kullanım Bozukluklarına Yaklaşım Rehberi, Prof. Dr. Hakan COŞKUNOL Uz. Dr. Cihan DÖĞER Dr. Belgin BAYRAK, Editor, T.C. Sağlık Bakanlığı, Ankara, pp.5-7, 2020

Benzodiazepinler, Diğer Yatıştırıcılar ve Hipnotikler

YALÇIN ŞAHİNER Ş.
in: Bağımlılık, Tanı, Tedavi, Önleme, PROF. DR. MÜCAHİT ÖZTÜRK, PROF. DR. KÜLTEGİN ÖGEL, DOÇ. DR. CÜNEYT EVREN, DOÇ. DR. RABİA BİLİCİ, Editor, YEŞİLAY YAYINLARI, TÜRKİYE YEŞİLAY CEMİYETİ, Gülmat Matbaacılık Yayıncılık San. Tic. Ltd. Şti., Ankara, pp.317-329, 2019

Opiyat Kullanım Bozuklukları

YALÇIN ŞAHİNER Ş.
in: Gençlerde Madde Bağımlılığının Önlenmesi, PROF.DR. ORHAN DERMAN, PROF. DR. NURAY KANBUR, DOÇ. DR. SİNEM AKGÜL, Editor, Akademisyen Kitabevi A.Ş., Ankara, pp.91-95, 2017